Role of Rotational Guided Growth in Management of Increased Femoral Anteversion

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06320769

Enrollment

Registered

2024-03-20

Start date

2024-02-20

Completion date

2026-03-01

Last updated

2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increased Femoral Anteversion

Keywords

Rotational Guided Growth, Torsional Deformities, Guided Growth, Rotational Deformities

Brief summary

Efficacy of guided growth in coronal plane deformity correction and limb length discrepancy has been well-established. Recently, studies have explored the validity of guided growth in correction of rotational deformity through a modified method of application. This concept has been validated in animal studies, biomechanical studies and two limited human case series through different methods. This study evaluates the efficacy of rotational guided growth in management of increased femoral anteversion using three different constructs.

Detailed description

The purpose of this study is: 1. Evaluate the efficacy of different constructs in correcting increased femoral anteversion clinically and radiographically. 2. Asses possible complications of this new concept including LLD, undesired coronal, sagittal plane deformity and stiffness.

Interventions

DEVICEPlate Technique

Using Plates, non-absorbable sutures or cerclage wires to guide the distal femoral physis towards rotational growth to correct deformity

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to 16 Years

Healthy volunteers

Inclusion criteria

* Children with increased femoral anteversion causing in-toeing with decreased agility. * Aged 8 years and above with at least two years of bone growth remaining.

Exclusion criteria

* Any patient who underwent previous femoral osteotomy. * Any patient with sick physis (skeletal dysplasias, post traumatic / post infective physeal damage, active rickets). * Cerebral Palsy (CP) patients

Design outcomes

Primary

Measure	Time frame	Description
Gait	12 months	Foot Progression Angle 5-10 degrees by clinical gait assesment

Secondary

Measure	Time frame	Description
Limb length discrepancy	12 months	Difference between length of both limbs through clinical measurement
Angular Deformities	12 months	CR radiographic measuement including angles such as MPTA, LDFA

Countries

Egypt

Contacts

Primary ContactAhmed Mohamed Mohamed Abdelghany Badr, Msc

abaghany@gmail.com+201060085397

Backup ContactTarek Hassan Abdelaziz

+201222421760

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026